Prelude Capital Management’s Transmedics TMDX Stock Holding History

Prelude Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Buy	2,586 +541	+26%	+$70.6K	0.02%	782
2025 Q4	$249K	Buy	+2,045	New	+$257K	0.02%	897
2024 Q1	–	Sell	-2,874	Closed	-$227K	–	1522
2023 Q4	$227K	Buy	+2,874	New	+$173K	0.02%	884
2019 Q4	–	Sell	-9,572	Closed	-$227K	–	2249
2019 Q3	$227K	Buy	9,572 +1,750	+22%	+$42K	0.01%	733
2019 Q2	$227K	Buy	+7,822	New	+$214K	0.01%	694

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's TMDX Position: Q1 2026 in Review

Prelude Capital Management increased its Transmedics (TMDX) stake by 26% in Q1 2026, buying an estimated $70.6K and bringing the position to 2,586 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #782.

Prelude Capital Management first reported a position in TMDX in Q2 2019 and has held it in 5 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Prelude Capital Management held 2,586 shares of Transmedics worth $257K as of Q1 2026.
Prelude Capital Management bought 541 Transmedics shares in Q1 2026, an estimated $70.6K.
Transmedics made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #782 holding.
Prelude Capital Management first reported a position in Transmedics in Q2 2019 and has held it in 5 quarters since.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.